She thought she was going to be a biotech patent IP lawyer, but ­Haurwitz’s love of science propelled her in another direction: partnering with famed biochemistry researcher Jennifer Doudna to cofound Caribou, one of the leading startups pursuing commercial applications of the ­genome-editing tool Crispr. So far Crispr-based research has largely focused on cancer, but the Texas native says Caribou’s gene therapies hold promise for ­modifying the body’s microorganisms to treat other illnesses. Her hobby: knitting.